title: Seroepidemiology of hepatitis A, B, and D viruses and human T-lymphocyte tropic viruses in Japanese drug abusers.
abstract: To evaluate the prevalence of hepatitis virus markers and human T-cell lymphotropic virus infections among drug abusers in Japan, serum samples were collected from 91 male drug abusers at the Shinshu University Hospital and the rehabilitation facility in Matsumoto and from 519 healthy male blood donors as controls. Sera were tested for antibody to hepatitis A virus (anti-HAV), hepatitis B surface antigen (HBsAg), antibody to HBsAg (anti-HBs), antibody to hepatitis B core antigen (anti-HBc), immunoglobulin M anti-HBc (IgM anti-HBc), antibody to hepatitis D virus (anti-HDV), antibody to HTLV type 1 (anti-HTLV 1), and antibody to human immunodeficiency virus (anti-HIV). The prevalence of anti-HAV was 13.2% in drug abusers and 10.8% in controls (not significant). The prevalences of HBsAg, anti-HBs, anti-HBc and exposure rate to hepatitis B virus (HBV) were 4.4%, 24.2%, 31.9%, and 35.2%, respectively, in drug abusers and 0.8%, 6.7%, 9.6%, and 9.6% in controls. The exposure rate to HBV was significantly different (P less than 0.001). IgM anti-HBc and anti-HDV were not detected in any sera. Anti-HTLV I was detected in three drug abusers (3.3%) and in one (0.2%) of the controls (P less than 0.01). All sera were negative for anti-HIV in all subjects. Infection with HBV and HTLV I is more common among drug abusers than in the general population of blood donors in Japan.
authors.affiliation: Department of Internal Medicine, Shinshu University School of Medicine, Nagano-ken, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Kiyosawa
authors.forename: H
authors.initials: H
authors.lastname: Oofusa
authors.forename: H
authors.initials: H
authors.lastname: Saitoh
authors.forename: T
authors.initials: T
authors.lastname: Sodeyama
authors.forename: E
authors.initials: E
authors.lastname: Tanaka
authors.forename: S
authors.initials: S
authors.lastname: Furuta
authors.forename: S
authors.initials: S
authors.lastname: Itoh
authors.forename: H
authors.initials: H
authors.lastname: Ogata
authors.forename: H
authors.initials: H
authors.lastname: Kobuchi
authors.forename: M
authors.initials: M
authors.lastname: Kameko
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000150:complications / Q000453:epidemiology* / Q000276:immunology; D000293:Adolescent; D000328:Adult; D017977:Deltaretrovirus / Q000276:immunology; D006678:HIV / Q000276:immunology; D015490:HTLV-I Infections / Q000150:complications / Q000453:epidemiology* / Q000276:immunology / Q000382:microbiology; D006514:Hepatitis B Surface Antigens / Q000032:analysis; D006515:Hepatitis B virus / Q000276:immunology; D003698:Hepatitis Delta Virus / Q000276:immunology; D006518:Hepatitis Viruses / Q000276:immunology; D006525:Hepatitis, Viral, Human / Q000150:complications / Q000453:epidemiology* / Q000276:immunology; D006507:Hepatovirus / Q000276:immunology; D006801:Humans; D007564:Japan / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D016036:Seroepidemiologic Studies; D019966:Substance-Related Disorders
chemical_list: D006514:Hepatitis B Surface Antigens